Great Point Partners’s NEVRO CORP. NVRO Stock Holding History

Great Point Partners’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-80,000	Closed	-$11.2M	–	38
2021 Q1	$11.2M	Buy	+80,000	New	+$13.1M	2.31%	19

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Great Point Partners's NVRO Position: Q2 2021 in Review

Great Point Partners sold out of NEVRO CORP. (NVRO) in Q2 2021, closing a stake of 80,000 shares — an estimated $11.2M sold.

Great Point Partners first reported a position in NVRO in Q1 2021 and held it in 1 quarter. The position peaked at $11.2M in Q1 2021. 207 funds tracked by Wall St. Rank hold NVRO as of Q2 2021.

Great Point Partners reported no remaining NEVRO CORP. position as of Q2 2021 after selling out during the quarter.
Great Point Partners sold 80,000 NEVRO CORP. shares in Q2 2021, an estimated $11.2M.
Great Point Partners first reported a position in NEVRO CORP. in Q1 2021 and held it in 1 quarter.
Great Point Partners's NEVRO CORP. position peaked at $11.2M in Q1 2021.
207 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2021.

Based on Great Point Partners's 13F filing for Q2 2021, filed 16 Aug 2021.